Uptake of 18F-fluorocholine, 18F-fluoroethyl-L- tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: Implications for separation of radiation necrosis from tumor recurrence

Journal of Nuclear Medicine

Volumn 45, Issue 11, 2004, Pages 1931-1938

  Spaeth, Nicolas ^a   Wyss, Matthias T ^a   Weber, Bruno ^a   Scheidegger, Stephan ^b   Lutz, Amelie ^a   Verwey, Jorn ^c   Radovanovic, Ivan ^d   Pahnke, Jens ^d   Wild, Damian ^a   Westera, Gerrit ^a   Weishaupt, Dominik ^a   Hermann, Dirk M ^e   Kaser Hotz, Barbara ^b   Aguzzi, Adriano ^d   Buck, Alfred ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c PAUL SCHERRER INSTITUTE   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

18F FDG; 18F fluorocholine; 18F fluoroethyl L tyrosine; Autoradiography; Radiation necrosis

Indexed keywords

FLUOROCHOLINE F 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHYL TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUOROMETHYL DIMETHYL 2 HYDROXYETHYLAMMONIUM; FLUOROMETHYL DIMETHYL-2-HYDROXYETHYLAMMONIUM; O (2 FLUOROETHYL)TYROSINE; O-(2-FLUOROETHYL)TYROSINE; QUATERNARY AMMONIUM DERIVATIVE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INJURY; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOLOGY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION NECROSIS; RAT; TUMOR RECURRENCE; ACUTE DISEASE; ANIMAL; BRAIN; BRAIN TUMOR; COMPARATIVE STUDY; EVALUATION; METABOLISM; NECROSIS; PATHOLOGY; RADIATION INJURY; SCINTISCANNING; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ANIMALS; BRAIN; BRAIN INJURIES; BRAIN NEOPLASMS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; MALE; NECROSIS; NEOPLASM RECURRENCE, LOCAL; QUATERNARY AMMONIUM COMPOUNDS; RADIATION INJURIES, EXPERIMENTAL; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

EID: 16544374226     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. 18F] fluorodeoxyglucose and positron emission tomography. Neurology. 1982;32:1323-1329.
2. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer. 2001;96:191-197.
3. 18F-fluorodeoxyglucose PET. AJR. 1994;163:1459-1465.
4. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR. 1998;19:407- 413.
5. Thompson TP, Lunsford LD, Kondziolka D. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg. 1999;73:9-14.
6. Del Sole A, Falini A, Ravasi L, et al. Anatomical and biochemical investigation of primary brain tumours. Eur J Nucl Med. 2001;28:1851-1872.
7. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology. 1986;158:149-155.
8. Mikhael MA. Radiation necrosis of the brain: correlation between computed tomography, pathology, and dose distribution. J Comput Assist Tomogr. 1978;2:71-80.
9. 18F]fluoro-D- glucose in tumor imaging with positron emission tomography. Mol Imaging Biol. 2002;4:267-273.
10. 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg. 2003;99:474-479.
11. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med. 2000;27:542-549.
12. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 1999;40:1367-1373.
13. 18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205-212.
14. 18F-FET) by dynamic PET in the differential diagnosis of malignant gliomas [abstract]. J Nucl Med. 2003;44(suppl):63P.
15. 18F-FET uptake and histologic grades of primary brain tumors [abstract]. J Nucl Med. 2003;44(suppl):367P.
16. Kaim AH, Weber B, Kurrer MO, et al. (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging. 2002;29:648-654.
17. Rau FC, Weber WA, Wester HJ, et al. O-(2-[(18)F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging. 2002;29:1039-1046.
18. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem. 1956;222:193-214.
19. Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr. 1981;1:95-121.
20. Haeffner EW. Studies on choline permeation through the plasma membrane and its incorporation into phosphatidyl choline of Ehrlich-Lettre-ascites tumor cells in vitro. Eur J Biochem. 1975;51:219 -228.
21. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res. 1996;16:1375-1380.
22. 11C-choline PET. J Nucl Med. 2000;41:1507-1513.
23. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990-995.
24. 11C]choline. J Nucl Med. 1997;38:842-847.
25. Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer. 1999;86:1638-1648.
26. Shinoura N, Nishijima M, Hara T, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997;202:497-503.
27. DeGrado TR, Baldwin SW, Wang S, et al. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001;42:1805-1814.
28. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging. 2004;31:312-316.
29. 18F]bromofluoromethane at high specific radioactivity. Appl Radiat Isot. 2001;54:927-933.
30. 11C]choline. Eur J Nucl Med. 2003;30(suppl):S311.
31. Egger E, Zografos L, Perret C. Proton beam irradiation of choroidal melanomas at PSI: technique and results. In: Sagerman RH, Alberti WE, eds. Medical Radiology: Diagnostic Imaging and Radiation Oncology - Radiotherapy of Intraocular and Orbital Tumors. New York, NY: Springer-Verlag; 1993:57-72.
32. Hermann DM, Kilic E, Kugler S, Isenmann S, Bahr M. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats. Neurobiol Dis. 2001;8:964-973.
33. Hermann DM, Mies G, Hossmann KA. Effects of a traumatic neocortical lesion on cerebral metabolism and gene expression of rats. Neuroreport. 1998;9:1917-1921.
34. Langen KJ, Jarosch M, Muhlensiepen H, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol. 2003;30:501-508.
35. Pauleit DO, Floeth F, Hamacher K, et al. Influence of blood-brain barrier disruption on FET uptake in cerebral gliomas [abstract]. J Nucl Med. 2003;44(suppl):244P.
36. 18F] fluoroethyltyrosine PET for the diagnosis of recurrent malignant astrocytomas [abstract]. J Nucl Med. 2003;44(suppl):166P.
37. Ohtani T, Kurihara H, Ishiuchi S, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med. 2001;28:1664-1670.
38. Takeda A, Tamano H, Enomoto S, Oku N. Zinc-65 imaging of rat brain tumors. Cancer Res. 2001;61:5065-5069.
39. The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE, eds. Radiation Injury to the Nervous System. New York, NY: Raven Press; 1991:191-208.